Skip to main content
Premium Trial:

Request an Annual Quote

Boschwitz Joins Orchid Cellmark, Caulfield Leaves Affy, Lewent Named to Thermo Fisher Board, and More

NEW YORK (GenomeWeb News) - Orchid Cellmark has appointed Jeffrey Boschwitz to be VP of North America marketing sales. Boschwitz formerly was director of marketing, planning, analysis, and research at Quest Diagnostics, and he was a principal in Booz Allen Hamilton’s healthcare practice.
 

 
Barbara Caulfield has resigned her role as executive VP and general counsel at Affymetrix and will leave the company on June 13 to take a position with a private law firm, according to a US Securities and Exchange Commission document. She will continue to serve as secretary to the company’s board of directors. 
 
Caulfield is taking members of her legal team from Affymetrix with her to the Dewey LeBoeuf law firm.  
 
Joining Caulfield in the East Palo Alto, Calif., office of the New York-based law firm are Michael Malacek and Peter Root as partners and Stephen Holmes as counsel.
 

 
Thermo Fisher Scientific has named Judy Lewent to its board of directors and has appointed her to its Strategy Review Committee. Lewent previously was executive VP and CFO of Merck, where she worked from 1980 to 2007. Lewent also has served on the boards at Dell and at Motorola, and she is a member of the MIT Corporation and a member of the American Academy of Arts and Sciences.
 

 
Heiner Dreismann has joined Med Biogene’s board of directors and he will chair the company’s Strategy Committee. Dreismann formerly was CEO of Roche Molecular Diagnostics, where he helped to introduce the company’s PCR products, expanded their diagnostic tests, and held several positions in global business development, R&D, and manufacturing.
 

 
The US Centers for Disease Control and Prevention has added five new members to its genomics working group. The Evaluation of Genomic Applications in Practice and Prevention Working Group includes specialists in genomics, healthcare, clinical and laboratory practice, ethics, epidemiology, public health, healthcare, and other related areas.
 
The latest additions to the EWG include: Doug Campos-Outcalt of the University of Arizona’s College of Medicine; Roger Klein of the H. Lee Moffitt Cancer Center & Research Institute, and the University of South Florida College of Medicine; Kenneth Offit of Memorial Sloan-Kettering Cancer Center; Stephen Pauker of Tufts Medical Center; and David Veenstra of the University of Washington.
 
Leaving EWG are Katrina Armstrong of the University of Pennsylvania’s School of Medicine, and Kathryn Phillips of the University of California San Francisco.
 

 
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.